Hella L Aberson Selected Research

Hella L Aberson Research Topics

4	Neoplasms (Cancer) 12/2020 - 11/2014
2	Adenocarcinoma 01/2022 - 09/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 11/2014
2	Inflammation (Inflammations) 09/2011 - 07/2009
1	COVID-19 01/2024
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2023
1	Disease Progression 11/2014
1	Edema (Dropsy) 09/2011
1	Colitis 09/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2009
1	Acute Coronary Syndrome 07/2009
1	Reperfusion Injury 07/2009
1	Osteosarcoma (Osteogenic Sarcoma) 12/2003

2	Gemcitabine FDA Link 01/2022 - 12/2020
2	Proteinase-Activated ReceptorsIBA 12/2020 - 11/2014
1	procollagen Type III-N-terminal peptide (PIIP)IBA 11/2023
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	DeoxycytidineIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Infliximab (Remicade)FDA Link 12/2020
1	Conditioned Culture MediaIBA 12/2020
1	Transcription Factors (Transcription Factor)IBA 09/2020
1	CCAAT-Enhancer-Binding ProteinsIBA 09/2020
1	AgarIBA 09/2020
1	CCAAT-Enhancer-Binding Protein-deltaIBA 09/2020
1	Peptide Hydrolases (Proteases)FDA Link 11/2014
1	FibrinIBA 09/2011
1	AnticoagulantsIBA 09/2011
1	Thromboplastin (Tissue Factor)IBA 09/2011
1	CytokinesIBA 09/2011
1	Dalteparin (Dalteparin Sodium)FDA Link 09/2011
1	ChemokinesIBA 09/2011
1	Protein CIBA 07/2009
1	Cytostatic AgentsIBA 12/2003

1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 07/2009